Grand Pharmaceutical Group Limited
Get $10 bonus on your first $100 deposit for 0512.HK
Get $10 bonus on your first $100 deposit for 0512.HK
Grand Pharmaceutical Group Limited (0512.HK) Stock Competitors & Peer Comparison
See (0512.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0512.HK | HK$7.22 | +0.98% | 25.3B | 12.24 | HK$0.59 | +3.60% |
| 3692.HK | HK$39.36 | +5.18% | 238.3B | 37.13 | HK$1.06 | +0.93% |
| 2196.HK | HK$20.80 | +1.66% | 77.9B | 14.44 | HK$1.44 | +1.68% |
| 0874.HK | HK$17.21 | +1.29% | 42.8B | 8.23 | HK$2.09 | +5.09% |
| 3320.HK | HK$6.27 | +1.95% | 39.4B | 8.59 | HK$0.73 | +2.15% |
| 0867.HK | HK$14.33 | +3.62% | 35B | 20.47 | HK$0.70 | +2.08% |
| 1513.HK | HK$29.20 | +2.03% | 31.9B | 11.32 | HK$2.58 | +4.11% |
| 3933.HK | HK$10.54 | +1.05% | 20.8B | 8.37 | HK$1.26 | +5.82% |
| 0013.HK | HK$23.56 | -1.34% | 20.3B | 5.68 | HK$4.15 | N/A |
| 9989.HK | HK$5.08 | +1.20% | 17.2B | 18.81 | HK$0.27 | +5.35% |
Stock Comparison
0512.HK vs 3692.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 3692.HK has a market cap of 238.3B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 3692.HK trades at HK$39.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 3692.HK's P/E ratio is 37.13. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 3692.HK's ROE of +0.16%. Regarding short-term risk, 0512.HK is less volatile compared to 3692.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 3692.HK's competition here
0512.HK vs 2196.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2196.HK has a market cap of 77.9B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2196.HK trades at HK$20.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2196.HK's P/E ratio is 14.44. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2196.HK's ROE of +0.09%. Regarding short-term risk, 0512.HK is less volatile compared to 2196.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2196.HK's competition here
0512.HK vs 0874.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0874.HK has a market cap of 42.8B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0874.HK trades at HK$17.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0874.HK's P/E ratio is 8.23. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0874.HK's ROE of +0.08%. Regarding short-term risk, 0512.HK is more volatile compared to 0874.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 0874.HK's competition here
0512.HK vs 3320.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 3320.HK has a market cap of 39.4B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 3320.HK trades at HK$6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 3320.HK's P/E ratio is 8.59. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 3320.HK's ROE of +0.08%. Regarding short-term risk, 0512.HK is less volatile compared to 3320.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 3320.HK's competition here
0512.HK vs 0867.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0867.HK has a market cap of 35B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0867.HK trades at HK$14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0867.HK's P/E ratio is 20.47. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0867.HK's ROE of +0.09%. Regarding short-term risk, 0512.HK is less volatile compared to 0867.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0867.HK's competition here
0512.HK vs 1513.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1513.HK has a market cap of 31.9B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1513.HK trades at HK$29.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1513.HK's P/E ratio is 11.32. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1513.HK's ROE of +0.14%. Regarding short-term risk, 0512.HK is less volatile compared to 1513.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 1513.HK's competition here
0512.HK vs 3933.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 3933.HK has a market cap of 20.8B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 3933.HK trades at HK$10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 3933.HK's P/E ratio is 8.37. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 3933.HK's ROE of +0.13%. Regarding short-term risk, 0512.HK is less volatile compared to 3933.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 3933.HK's competition here
0512.HK vs 0013.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0013.HK has a market cap of 20.3B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0013.HK trades at HK$23.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0013.HK's P/E ratio is 5.68. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0013.HK's ROE of +0.41%. Regarding short-term risk, 0512.HK is less volatile compared to 0013.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0013.HK's competition here
0512.HK vs 9989.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 9989.HK has a market cap of 17.2B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 9989.HK trades at HK$5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 9989.HK's P/E ratio is 18.81. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 9989.HK's ROE of +0.03%. Regarding short-term risk, 0512.HK is more volatile compared to 9989.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 9989.HK's competition here
0512.HK vs 2575.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2575.HK has a market cap of 16.1B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2575.HK trades at HK$31.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2575.HK's P/E ratio is -51.77. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2575.HK's ROE of -0.54%. Regarding short-term risk, 0512.HK is less volatile compared to 2575.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2575.HK's competition here
0512.HK vs 1681.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1681.HK has a market cap of 14.4B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1681.HK trades at HK$17.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1681.HK's P/E ratio is 11.94. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1681.HK's ROE of +0.24%. Regarding short-term risk, 0512.HK is less volatile compared to 1681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 1681.HK's competition here
0512.HK vs 1558.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1558.HK has a market cap of 14B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1558.HK trades at HK$15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1558.HK's P/E ratio is 26.47. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1558.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is less volatile compared to 1558.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 1558.HK's competition here
0512.HK vs 0460.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0460.HK has a market cap of 12.9B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0460.HK trades at HK$1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0460.HK's P/E ratio is 70.50. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0460.HK's ROE of -0.02%. Regarding short-term risk, 0512.HK is less volatile compared to 0460.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0460.HK's competition here
0512.HK vs 6185.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 6185.HK has a market cap of 11.6B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 6185.HK trades at HK$33.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 6185.HK's P/E ratio is -43.47. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 6185.HK's ROE of +0.01%. Regarding short-term risk, 0512.HK is less volatile compared to 6185.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 6185.HK's competition here
0512.HK vs 2627.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2627.HK has a market cap of 10.6B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2627.HK trades at HK$29.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2627.HK's P/E ratio is -45.11. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2627.HK's ROE of -1.43%. Regarding short-term risk, 0512.HK is less volatile compared to 2627.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2627.HK's competition here
0512.HK vs 0719.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0719.HK has a market cap of 9.6B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0719.HK trades at HK$6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0719.HK's P/E ratio is 13.33. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0719.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is more volatile compared to 0719.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 0719.HK's competition here
0512.HK vs 0570.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0570.HK has a market cap of 9.1B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0570.HK trades at HK$1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0570.HK's P/E ratio is -22.50. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0570.HK's ROE of -0.02%. Regarding short-term risk, 0512.HK is more volatile compared to 0570.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 0570.HK's competition here
0512.HK vs 2005.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2005.HK has a market cap of 7.4B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2005.HK trades at HK$2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2005.HK's P/E ratio is 15.63. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2005.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is less volatile compared to 2005.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2005.HK's competition here
0512.HK vs 2877.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2877.HK has a market cap of 7.4B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2877.HK trades at HK$9.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2877.HK's P/E ratio is 6.83. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2877.HK's ROE of +0.12%. Regarding short-term risk, 0512.HK is less volatile compared to 2877.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2877.HK's competition here
0512.HK vs 2552.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2552.HK has a market cap of 3.6B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2552.HK trades at HK$3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2552.HK's P/E ratio is 2.87. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2552.HK's ROE of +1.07%. Regarding short-term risk, 0512.HK is less volatile compared to 2552.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2552.HK's competition here
0512.HK vs 6896.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 6896.HK has a market cap of 2.7B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 6896.HK trades at HK$3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 6896.HK's P/E ratio is 8.98. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 6896.HK's ROE of +0.20%. Regarding short-term risk, 0512.HK is more volatile compared to 6896.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 6896.HK's competition here
0512.HK vs 2561.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2561.HK has a market cap of 2.7B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2561.HK trades at HK$24.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2561.HK's P/E ratio is -8.95. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2561.HK's ROE of -0.26%. Regarding short-term risk, 0512.HK is less volatile compared to 2561.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 2561.HK's competition here
0512.HK vs 2633.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2633.HK has a market cap of 2.5B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2633.HK trades at HK$1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2633.HK's P/E ratio is 8.33. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2633.HK's ROE of +0.13%. Regarding short-term risk, 0512.HK is more volatile compared to 2633.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 2633.HK's competition here
0512.HK vs 2161.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2161.HK has a market cap of 2.2B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2161.HK trades at HK$2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2161.HK's P/E ratio is 9.81. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2161.HK's ROE of +0.20%. Regarding short-term risk, 0512.HK is more volatile compared to 2161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 2161.HK's competition here
0512.HK vs 1061.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1061.HK has a market cap of 2.1B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1061.HK trades at HK$3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1061.HK's P/E ratio is 6.46. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1061.HK's ROE of +0.14%. Regarding short-term risk, 0512.HK is less volatile compared to 1061.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 1061.HK's competition here
0512.HK vs 2348.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 2348.HK has a market cap of 1.7B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 2348.HK trades at HK$1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 2348.HK's P/E ratio is 8.92. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 2348.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is more volatile compared to 2348.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 2348.HK's competition here
0512.HK vs 3839.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 3839.HK has a market cap of 1.6B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 3839.HK trades at HK$6.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 3839.HK's P/E ratio is 6.90. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 3839.HK's ROE of +0.12%. Regarding short-term risk, 0512.HK is more volatile compared to 3839.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 3839.HK's competition here
0512.HK vs 8049.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 8049.HK has a market cap of 1.3B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 8049.HK trades at HK$2.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 8049.HK's P/E ratio is 6.30. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 8049.HK's ROE of +0.08%. Regarding short-term risk, 0512.HK is more volatile compared to 8049.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 8049.HK's competition here
0512.HK vs 1349.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1349.HK has a market cap of 1B. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1349.HK trades at HK$2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1349.HK's P/E ratio is -99.00. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1349.HK's ROE of -0.07%. Regarding short-term risk, 0512.HK is less volatile compared to 1349.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 1349.HK's competition here
0512.HK vs 1652.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1652.HK has a market cap of 931.5M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1652.HK trades at HK$1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1652.HK's P/E ratio is -4.67. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1652.HK's ROE of -0.49%. Regarding short-term risk, 0512.HK is less volatile compared to 1652.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 1652.HK's competition here
0512.HK vs 0503.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0503.HK has a market cap of 750.6M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0503.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0503.HK's P/E ratio is 13.77. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0503.HK's ROE of +0.07%. Regarding short-term risk, 0512.HK is less volatile compared to 0503.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0503.HK's competition here
0512.HK vs 0239.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0239.HK has a market cap of 747.9M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0239.HK trades at HK$2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0239.HK's P/E ratio is 10.43. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0239.HK's ROE of +0.10%. Regarding short-term risk, 0512.HK is less volatile compared to 0239.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0239.HK's competition here
0512.HK vs 0950.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0950.HK has a market cap of 712.5M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0950.HK trades at HK$1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0950.HK's P/E ratio is 7.56. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0950.HK's ROE of +0.05%. Regarding short-term risk, 0512.HK is less volatile compared to 0950.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0950.HK's competition here
0512.HK vs 3737.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 3737.HK has a market cap of 675M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 3737.HK trades at HK$0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 3737.HK's P/E ratio is 40.00. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 3737.HK's ROE of +0.02%. Regarding short-term risk, 0512.HK is less volatile compared to 3737.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 3737.HK's competition here
0512.HK vs 1011.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1011.HK has a market cap of 485.5M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1011.HK trades at HK$0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1011.HK's P/E ratio is -2.67. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1011.HK's ROE of +0.21%. Regarding short-term risk, 0512.HK is more volatile compared to 1011.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 1011.HK's competition here
0512.HK vs 0897.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0897.HK has a market cap of 416.3M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0897.HK trades at HK$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0897.HK's P/E ratio is -37.00. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0897.HK's ROE of -0.01%. Regarding short-term risk, 0512.HK is less volatile compared to 0897.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0897.HK's competition here
0512.HK vs 0858.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0858.HK has a market cap of 211.7M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0858.HK trades at HK$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0858.HK's P/E ratio is -0.55. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0858.HK's ROE of -0.30%. Regarding short-term risk, 0512.HK is less volatile compared to 0858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0858.HK's competition here
0512.HK vs 0455.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0455.HK has a market cap of 208.6M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0455.HK trades at HK$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0455.HK's P/E ratio is -3.23. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0455.HK's ROE of -0.15%. Regarding short-term risk, 0512.HK is less volatile compared to 0455.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 0455.HK's competition here
0512.HK vs 8329.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 8329.HK has a market cap of 206.4M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 8329.HK trades at HK$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 8329.HK's P/E ratio is -4.10. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 8329.HK's ROE of -0.06%. Regarding short-term risk, 0512.HK is less volatile compared to 8329.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 8329.HK's competition here
0512.HK vs 8622.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 8622.HK has a market cap of 177.8M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 8622.HK trades at HK$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 8622.HK's P/E ratio is -34.50. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 8622.HK's ROE of -0.07%. Regarding short-term risk, 0512.HK is less volatile compared to 8622.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.Check 8622.HK's competition here
0512.HK vs 1498.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 1498.HK has a market cap of 127.7M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 1498.HK trades at HK$0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 1498.HK's P/E ratio is -3.39. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 1498.HK's ROE of -0.30%. Regarding short-term risk, 0512.HK is more volatile compared to 1498.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 1498.HK's competition here
0512.HK vs 0911.HK Comparison April 2026
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 25.3B. In comparison, 0911.HK has a market cap of 44.9M. Regarding current trading prices, 0512.HK is priced at HK$7.22, while 0911.HK trades at HK$0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.24, whereas 0911.HK's P/E ratio is 0.08. In terms of profitability, 0512.HK's ROE is +0.07%, compared to 0911.HK's ROE of +0.01%. Regarding short-term risk, 0512.HK is more volatile compared to 0911.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.Check 0911.HK's competition here